- Home
- NRC vs RNAC Comparison
NRC vs RNAC Comparison
Compare NRC & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRC
- RNAC
- Stock Information
- Founded
- NRC 1981
- RNAC 2007
- Country
- NRC United States
- RNAC United States
- Employees
- NRC N/A
- RNAC N/A
- Industry
- NRC Biotechnology: Commercial Physical & Biological Resarch
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- NRC Health Care
- RNAC Health Care
- Exchange
- NRC Nasdaq
- RNAC Nasdaq
- Market Cap
- NRC 354.5M
- RNAC 276.3M
- IPO Year
- NRC N/A
- RNAC 2016
- Fundamental
- Price
- NRC $14.65
- RNAC $10.05
- Analyst Decision
- NRC
- RNAC Strong Buy
- Analyst Count
- NRC 0
- RNAC 4
- Target Price
- NRC N/A
- RNAC $40.00
- AVG Volume (30 Days)
- NRC 101.8K
- RNAC 48.4K
- Earning Date
- NRC 10-24-2025
- RNAC 08-07-2025
- Dividend Yield
- NRC 3.27%
- RNAC N/A
- EPS Growth
- NRC N/A
- RNAC N/A
- EPS
- NRC 0.77
- RNAC N/A
- Revenue
- NRC $140,314,000.00
- RNAC $1,026,000.00
- Revenue This Year
- NRC N/A
- RNAC N/A
- Revenue Next Year
- NRC N/A
- RNAC N/A
- P/E Ratio
- NRC $19.08
- RNAC N/A
- Revenue Growth
- NRC N/A
- RNAC N/A
- 52 Week Low
- NRC $9.76
- RNAC $8.46
- 52 Week High
- NRC $22.99
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- NRC 47.80
- RNAC 34.71
- Support Level
- NRC $14.45
- RNAC $10.50
- Resistance Level
- NRC $15.60
- RNAC $11.80
- Average True Range (ATR)
- NRC 0.64
- RNAC 0.56
- MACD
- NRC -0.03
- RNAC -0.11
- Stochastic Oscillator
- NRC 17.05
- RNAC 0.45
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.